SCHEMBL6170251

SCHEMBL6170251

CC(c1ccncc1C(=N)N)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.33
LMNA P02545 1/20 0.32
NAMPT P43490 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175175 0.86 IGF1R (0.36) IGF1RLMNA
SCHEMBL6174658 0.84 RXFP1 (0.34) IGF1RLMNA
SCHEMBL6175990 0.84 KIF11 (0.37) IGF1RLMNANAMPT
SCHEMBL6171408 0.84 IGF1R (0.35) IGF1RLMNA
SCHEMBL6173330 0.84 IGF1R (0.40) IGF1RLMNANAMPT
SCHEMBL6175260 0.83 IGF1R (0.39) IGF1RLMNANAMPT
SCHEMBL6172002 0.83 LMNA (0.41) IGF1RLMNA
SCHEMBL6174116 0.82 IGF1R (0.33) IGF1RLMNA
SCHEMBL6176021 0.82 IGF1R (0.34) IGF1RLMNA
SCHEMBL6175297 0.81 LMNA (0.39) IGF1RLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed